OBJECTIVE: To validate the Thai version of the Scale for Outcomes in Parkinson 's disease-Sleep Scale (SCOPA-Sleep scale)for assessment of nighttime sleep problems (NSP) and daytime sleepiness (DS). MATERIAL AND METHOD: A Thai version of SCOPA-Sleep scale has been developed with the permission of the originator. Fifty-one patients with Parkinson's disease were asked to complete the Thai SCOPA-Sleep scale (consisting of NSP and DS sections), plus the Pittsburg Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS). A second group of twenty patients completed the Thai SCOPA-Sleep scale, twice, two weeks apart. The reliability and validity were subsequently analyzed. RESULTS: The Thai SCOPA-Sleep scale showed a Cronbach 's alpha coefficient of 0.87 and 0.74 for SCOPA-NSP and SCOPA-DS, respectively with no significant difference between initial and follow-up scores. The content validity of SCOPA-NSP and SCOPA-DS were 0.9 and 0.9, respectively. There was a strong correlation between the Thai SCOPA-NSP and PSQI as well as the Thai SCOPA-DS and ESS (p < 0.01 and p < 0.01, respectively). CONCLUSION: The Thai SCOPA-Sleep scale is a reliable, valid instrument for assessing NSP and DS
OBJECTIVE: To validate the Thai version of the Scale for Outcomes in Parkinson 's disease-Sleep Scale (SCOPA-Sleep scale)for assessment of nighttime sleep problems (NSP) and daytime sleepiness (DS). MATERIAL AND METHOD: A Thai version of SCOPA-Sleep scale has been developed with the permission of the originator. Fifty-one patients with Parkinson's disease were asked to complete the Thai SCOPA-Sleep scale (consisting of NSP and DS sections), plus the Pittsburg Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS). A second group of twenty patients completed the Thai SCOPA-Sleep scale, twice, two weeks apart. The reliability and validity were subsequently analyzed. RESULTS: The Thai SCOPA-Sleep scale showed a Cronbach 's alpha coefficient of 0.87 and 0.74 for SCOPA-NSP and SCOPA-DS, respectively with no significant difference between initial and follow-up scores. The content validity of SCOPA-NSP and SCOPA-DS were 0.9 and 0.9, respectively. There was a strong correlation between the Thai SCOPA-NSP and PSQI as well as the Thai SCOPA-DS and ESS (p < 0.01 and p < 0.01, respectively). CONCLUSION: The Thai SCOPA-Sleep scale is a reliable, valid instrument for assessing NSP and DS
Authors: Young Hee Sung; Hee Jin Kim; Seong Beom Koh; Joong Seok Kim; Sang Jin Kim; Sang Myung Cheon; Jin Whan Cho; Yoon Joong Kim; Hyeo Il Ma; Mee Young Park; Jong Sam Baik; Phil Hyu Lee; Sun Ju Chung; Jong Min Kim; In Uk Song; Han Joon Kim; Ji Young Kim; Do Young Kwon; Jae Hyeok Lee; Jee Young Lee; Ji Seon Kim; Ji Young Yun; Jin Yong Hong; Mi Jung Kim; Jinyoung Youn; Ji Sun Kim; Eung Seok Oh; Hui Jun Yang; Won Tae Yoon; Sooyeoun You; Kyum Yil Kwon; Hyung Eun Park; Su Yun Lee; Younsoo Kim; Hee Tae Kim; Tae Beom Ahn Journal: J Korean Med Sci Date: 2018-01-08 Impact factor: 2.153